Jaguar Signs Distribution Agreement for Japan for Neonorm Foal & Neonorm Calf
Jaguar Receives Extension of Nasdaq Listing
Neonorm™ Foal is a natural, clinically-tested, non-drug product designed for use as an anti-diarrheal in newborn horses. Diarrhea is one of the most common clinical complaints in foals, especially within the first 30 days of life. The crippling effects of dehydration that often result from secretory diarrhea in foals can manifest quickly, precipitate adverse health effects and lead to death. Neonorm™ Calf has been formulated and clinically tested to help proactively retain fluid in dairy calves and reduce the severity of diarrhea—aiding calves in avoiding debilitating, dangerous levels of dehydration associated with scours.
In the year 2000, there were an estimated 115,000 horses in
“We’re very excited to represent Neonorm™ Foal and Neonorm™
Extension of Nasdaq Listing
Jaguar also announced today that, on
For more information about Jaguar, please visit www.jaguaranimalhealth.com.
Certain statements in this press release constitute “forward-looking
statements.” These include statements regarding the completion of
Jaguar’s proposed merger with
1A. Fotovati1, Y. Mizuno, T. Ito and H. Moriyama, A
Statistical Study of the Horse Industry in
2The Food and Beverage Market Entry Handbook:
KCSA Strategic Communications
Garth Russell, 212-896-1250